Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
TETRA Technologies
TTI
$1.29B
| $2.56M | 0.01% |
341,083
+325,652
| +2,110% | +$2.53M |
|
|
GSB
1952
DELISTED
GlobalSCAPE, Inc.
GSB
| $2.56M | 0.01% |
638,500
+85,210
| +15% | +$317K |
|
1953
Escalade
ESCA
$284M
| $2.56M | 0.01% |
192,800
-1,300
| -0.7% | -$18.4K |
|
|
CORR
1954
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $2.55M | 0.01% |
171,961
+147,615
| +606% | +$3.27M |
|
|
PGEM
1955
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $2.55M | 0.01% |
203,100
+68,300
| +51% | +$850K |
|
1956
Alpha Pro Tech
APT
$54.8M
| $2.54M | 0.01% |
1,452,998
-4,200
| -0.3% | -$7.88K |
|
|
CNSL
1957
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $2.54M | 0.01% |
121,355
-43,600
| -26% | -$924K |
|
1958
PC Connection
CNXN
$2.03B
| $2.54M | 0.01% |
112,112
+13,412
| +14% | +$293K |
|
1959
Great Elm Group
GEG
$69M
| $2.54M | 0.01% |
244,821
+23,594
| +11% | +$246K |
|
1960
Friedman Industries
FRD
$324M
| $2.53M | 0.01% |
457,300
+3,900
| +0.9% | +$23K |
|
|
UPL
1961
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $2.53M | 0.01% |
+1,011,431
| New | +$4.71M |
|
|
CSII
1962
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.53M | 0.01% |
167,200
+40,661
| +32% | +$604K |
|
1963
Crocs
CROX
$6.26B
| $2.52M | 0.01% |
246,168
+111,074
| +82% | +$1.2M |
|
|
HTWR
1964
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $2.52M | 0.01% |
+50,000
| New | +$2.35M |
|
1965
Dine Brands
DIN
$462M
| $2.52M | 0.01% |
29,700
-8,100
| -21% | -$694K |
|
1966
Team
TISI
$101M
| $2.52M | 0.01% |
7,870
+2,180
| +38% | +$770K |
|
|
SLI
1967
DELISTED
S L INDUSTRIES INC (DELAWARE)
SLI
| $2.51M | 0.01% |
78,800
+3,600
| +5% | +$121K |
|
|
IBKC
1968
DELISTED
IBERIABANK Corp
IBKC
| $2.51M | 0.01% |
+45,600
| New | +$2.72M |
|
|
RLH
1969
DELISTED
Red Lions Hotel Corporation
RLH
| $2.51M | 0.01% |
357,800
+73,700
| +26% | +$573K |
|
|
PTX
1970
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $2.5M | 0.01% |
84,782
+38,422
| +83% | +$1.16M |
|
1971
Banco Santander Chile
BSAC
$16B
| $2.5M | 0.01% |
141,700
+85,500
| +152% | +$1.59M |
|
1972
Global Indemnity Group
GBLI
$409M
| $2.5M | 0.01% |
86,164
+7,200
| +9% | +$202K |
|
|
IXYS
1973
DELISTED
IXYS Corp
IXYS
| $2.5M | 0.01% |
197,672
-43,500
| -18% | -$542K |
|
|
ATTU
1974
DELISTED
Attunity Ltd
ATTU
| $2.5M | 0.01% |
225,833
+60,653
| +37% | +$763K |
|
|
AVEO
1975
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.49M | 0.01% |
197,590
-11,590
| -6% | -$138K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.